Liaoning Medical Diagnosis And Treatment Technology Research And Development Co., Ltd.

This early-stage study tests whether a single treatment with human umbilical cord stem cells is safe and tolerable for people with Parkinson's disease. About 20 adults aged 18 to 75 will receive either stem cells or a placebo, and researchers will monitor side effects and any cha…

This early-phase study tests whether a personalized therapy using a patient's own immune cells can safely control advanced solid tumors like lung, liver, colorectal, and breast cancers. Researchers will take blood, grow special immune cells in a lab, and infuse them back to help …